Stocks
GlaxoSmithKline (GSK) P/FCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | 13.3 | 0.00 | 0.00 | 19.3 | 8.53 | 16.3 | |||
| Changes by years, y/y, % | +18% | -100% | -56% | -5.4% | |||||
GlaxoSmithKline. P/FCF
GlaxoSmithKline. P/FCF, changes, %
GlaxoSmithKline (GSK) P/FCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| P/FCF | 20.4 | 16.7 | 14.6 | 7.90 | 17.8 | 16.3 | ||
| Changes by years, y/y, % | +3% | -54% | -13% | |||||
| Changes by quarters, q/q, % | +20% | -18% | -13% | -46% | +125% | |||
